Sairah Ahmed

ARS Appropriate Use Criteria voor extranodale NK/T-cellymfoom

Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Older Patiënten met Gevorderd-Stage Classic Hodgkin Lymphoma Enrolled...

Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapy.

Nivolumab plus AVD bij gevorderd klassiek hodgkinlymfoom: SWOG S1826 fase III